Biocon Q3 net profit falls 17% to Rs 169 crore, revenue up 7% The biosimilars and research services segment posted 11 per cent and 13 per cent growth, respectively, in their income during the quarter, while the generics business recorded a 3 per cent decline BusinessToday.In | January 22, 2021 | Updated 17:39 IST Biocon Executive Chairperson Kiran Mazumdar-Shaw Biocon Ltd on Thursday reported a 17 per cent decline in consolidated net profit for October-December quarter of the ongoing financial year at Rs 169 crore. The company had posted a net profit of Rs 203 crore in the year-ago quarter. However, its revenue rose 7 per cent to Rs 1,879 crore during the quarter ended December, led by double-digit growth in research services and biosimilars business segments.